17 employees
Ziccum is developing new dry-powder versions of the world’s most effective vaccines and biologic pharmaceuticals.
2017
$84K
from 1 investors over 1 rounds
Ziccum AB raised $84K on August 1, 2018
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)